Adar Poonawalla, CEO Serum Institute of India announced that the company has started manufacturing the first batch of Novovax's Covid vaccine Covovax . In a tweet Poonawalla said "Excited to witness the first batch of Covovax being manufactured this week at our facility in Pune. The vaccine has great potential to protect our future generations below the age of 18. Trials are ongoing."
Serum has partnered with US biotech company Novavax to conduct bridge trials on the jab and manufacture the vaccine. The govt expects the vaccine to be available from August to December though has not signed any supply contract with SII for the same yet.